X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (33787) 33787
Newspaper Article (582) 582
Book Chapter (381) 381
Newsletter (147) 147
Book / eBook (82) 82
Magazine Article (61) 61
Web Resource (11) 11
Conference Proceeding (9) 9
Dissertation (7) 7
Reference (4) 4
Book Review (3) 3
Publication (3) 3
Trade Publication Article (3) 3
Government Document (2) 2
Streaming Video (2) 2
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29379) 29379
science & technology (24827) 24827
life sciences & biomedicine (23072) 23072
female (13932) 13932
male (13349) 13349
oncology (12945) 12945
brain neoplasms - drug therapy (12565) 12565
middle aged (8943) 8943
animals (8827) 8827
adult (8650) 8650
brain neoplasms - pathology (8102) 8102
neurosciences & neurology (7779) 7779
clinical neurology (6657) 6657
aged (6455) 6455
cancer (5847) 5847
brain tumors (5438) 5438
chemotherapy (5153) 5153
tumors (5145) 5145
cell line, tumor (4851) 4851
brain cancer (4674) 4674
brain neoplasms - metabolism (4332) 4332
glioblastoma (4281) 4281
mice (4126) 4126
treatment outcome (4028) 4028
glioma - drug therapy (4014) 4014
brain neoplasms - therapy (3995) 3995
glioma (3847) 3847
glioblastoma - drug therapy (3820) 3820
gliomas (3795) 3795
brain neoplasms - radiotherapy (3774) 3774
brain neoplasms - secondary (3761) 3761
magnetic resonance imaging (3718) 3718
medicine & public health (3694) 3694
child (3623) 3623
care and treatment (3562) 3562
surgery (3524) 3524
brain (3515) 3515
adolescent (3452) 3452
antineoplastic agents - therapeutic use (3347) 3347
brain neoplasms - genetics (3315) 3315
prognosis (3315) 3315
glioma - pathology (3298) 3298
combined modality therapy (3129) 3129
research (2976) 2976
glioblastoma - pathology (2939) 2939
antineoplastic combined chemotherapy protocols - therapeutic use (2884) 2884
metastasis (2880) 2880
glioblastoma multiforme (2862) 2862
neurology (2853) 2853
neurosciences (2773) 2773
brain neoplasms - surgery (2654) 2654
analysis (2575) 2575
cancer therapies (2476) 2476
apoptosis (2429) 2429
health aspects (2421) 2421
radiotherapy (2419) 2419
rats (2410) 2410
brain neoplasms - mortality (2391) 2391
retrospective studies (2342) 2342
child, preschool (2315) 2315
brain neoplasms - diagnosis (2151) 2151
abridged index medicus (2108) 2108
dacarbazine - analogs & derivatives (2040) 2040
patients (2037) 2037
medicine (1967) 1967
cell biology (1961) 1961
radiation therapy (1947) 1947
proteins (1907) 1907
gene expression (1873) 1873
pharmacology & pharmacy (1862) 1862
brain - pathology (1817) 1817
glioma - metabolism (1812) 1812
glioblastoma - metabolism (1784) 1784
pediatrics (1768) 1768
research article (1744) 1744
science & technology - other topics (1737) 1737
medical prognosis (1733) 1733
neurosurgery (1713) 1713
young adult (1696) 1696
aged, 80 and over (1676) 1676
survival analysis (1673) 1673
temozolomide (1672) 1672
follow-up studies (1640) 1640
mice, nude (1640) 1640
brain neoplasms - complications (1631) 1631
development and progression (1590) 1590
drug therapy (1581) 1581
antineoplastic agents - pharmacology (1575) 1575
stem cells (1538) 1538
breast cancer (1522) 1522
radiology, nuclear medicine & medical imaging (1514) 1514
antineoplastic agents - administration & dosage (1503) 1503
survival rate (1494) 1494
mutation (1463) 1463
glioblastoma - genetics (1460) 1460
multidisciplinary sciences (1451) 1451
time factors (1451) 1451
tumor cells, cultured (1433) 1433
kinases (1421) 1421
signal transduction (1419) 1419
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (17) 17
Online Resources - Online (10) 10
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Scarborough Hospital - Online (2) 2
Baycrest Hospital - Stacks (1) 1
Credit Valley Hospital - Online (1) 1
Credit Valley Hospital - Reference (1) 1
Credit Valley Hospital - Reserve desk (1) 1
St. Michael's College (John M. Kelly) - Circulation Desk (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (33584) 33584
Japanese (712) 712
French (367) 367
German (355) 355
Russian (166) 166
Spanish (122) 122
Chinese (121) 121
Italian (76) 76
Polish (55) 55
Dutch (27) 27
Danish (22) 22
Portuguese (21) 21
Hungarian (19) 19
Norwegian (10) 10
Czech (9) 9
Swedish (7) 7
Hebrew (6) 6
Romanian (5) 5
Korean (4) 4
Serbian (4) 4
Turkish (4) 4
Ukrainian (4) 4
Finnish (3) 3
Slovak (3) 3
Slovenian (3) 3
Croatian (2) 2
Arabic (1) 1
Bulgarian (1) 1
Corsican (1) 1
Icelandic (1) 1
Latvian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2012, ISBN 9780791860038, viii, 99
Book
Seminars in oncology, ISSN 0093-7754, 2015, Volume 42, Issue 6, pp. 801 - 819
.... Most of these molecular alterations promote multiple steps of carcinogenesis in FGFR oncogene-addicted cells, increasing cell proliferation, angiogenesis, and drug resistance... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplasms - metabolism | Gastrointestinal Neoplasms - genetics | Gastrointestinal Neoplasms - drug therapy | Humans | Brain Neoplasms - pathology | Fibroblast Growth Factors - genetics | Brain Neoplasms - metabolism | Head and Neck Neoplasms - metabolism | Breast Neoplasms - metabolism | Fibroblast Growth Factors - metabolism | Gastrointestinal Neoplasms - pathology | Glioblastoma - genetics | Receptors, Fibroblast Growth Factor - genetics | Female | Glioblastoma - metabolism | Antineoplastic Agents - pharmacology | Molecular Targeted Therapy - methods | Gastrointestinal Neoplasms - metabolism | Biomarkers, Tumor - analysis | Head and Neck Neoplasms - drug therapy | Receptors, Fibroblast Growth Factor - antagonists & inhibitors | Thoracic Neoplasms - pathology | Brain Neoplasms - genetics | Brain Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Thoracic Neoplasms - metabolism | Head and Neck Neoplasms - pathology | Neoplasms - drug therapy | Breast Neoplasms - genetics | Thoracic Neoplasms - genetics | Breast Neoplasms - pathology | Glioblastoma - pathology | Receptors, Fibroblast Growth Factor - metabolism | Head and Neck Neoplasms - genetics | Fibroblast Growth Factors - antagonists & inhibitors | Thoracic Neoplasms - drug therapy | Glioblastoma - drug therapy | Neoplasms - pathology | Drug Resistance, Neoplasm - physiology | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 76, Issue 5, pp. 1360 - 1368
... followed by chemoradiotherapy with intensity-modulated radiation therapy (C-IMRT) for head-and-neck cancer patients... 
Radiology | Hematology, Oncology and Palliative Medicine | Head and neck cancer | Volume changes | Chemo-IMRT | Dosimetric changes | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Laryngeal Neoplasms - radiotherapy | Prospective Studies | Humans | Oropharyngeal Neoplasms - diagnostic imaging | Spinal Cord - radiation effects | Laryngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - pathology | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - radiotherapy | Fluorouracil - administration & dosage | Time Factors | Laryngeal Neoplasms - drug therapy | Nasopharyngeal Neoplasms - drug therapy | Brain Stem - radiation effects | Radiotherapy Dosage | Nasopharyngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - drug therapy | Parotid Gland - diagnostic imaging | Head and Neck Neoplasms - diagnostic imaging | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Tumor Burden | Head and Neck Neoplasms - pathology | Radiography | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Parotid Gland - radiation effects | Hypopharyngeal Neoplasms - pathology | Combined Modality Therapy - methods | Hypopharyngeal Neoplasms - drug therapy | Hypopharyngeal Neoplasms - diagnostic imaging | Care and treatment | Chemotherapy | Oncology, Experimental | Radiation | Research | Radiotherapy | Cancer | Index Medicus | TOMOGRAPHY | HEAD | DIAGNOSTIC TECHNIQUES | NEOPLASMS | RADIATION DOSES | MEDICINE | COMPUTERIZED TOMOGRAPHY | CHEMOTHERAPY | NUCLEAR MEDICINE | CAT SCANNING | DISEASES | THERAPY | DOSES | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY | BODY | COMBINED THERAPY | RADIOLOGY
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2011, Volume 81, Issue 1, pp. 126 - 134
Purpose To perform a comprehensive cognitive function (CF) assessment in patients who were relapse free after curative intent radiotherapy (RT... 
Radiology | Hematology, Oncology and Palliative Medicine | Squamous cell carcinoma of the head and neck | Chemotherapy | Neuropsychological testing | Radiotherapy | Cognitive dysfunction | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Laryngeal Neoplasms - radiotherapy | Pharyngeal Neoplasms - radiotherapy | Cerebellum - radiation effects | Prospective Studies | Humans | Middle Aged | Male | Pharyngeal Neoplasms - drug therapy | Antineoplastic Agents - administration & dosage | Cognition - physiology | Laryngeal Neoplasms - drug therapy | Neoplasms, Squamous Cell - pathology | Carcinoma - drug therapy | Carcinoma - blood | Affect - physiology | Head and Neck Neoplasms - drug therapy | Cognition - drug effects | Neoplasms, Squamous Cell - blood | Head and Neck Neoplasms - pathology | Carcinoma, Squamous Cell | Neuropsychological Tests | Cognition Disorders - diagnosis | Memory Disorders - etiology | Hypopharyngeal Neoplasms - pathology | Quality of Life | Pharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - drug therapy | Temporal Lobe - drug effects | Laryngeal Neoplasms - blood | Cerebellum - drug effects | Hypopharyngeal Neoplasms - blood | Cisplatin - administration & dosage | Feasibility Studies | Laryngeal Neoplasms - pathology | Squamous Cell Carcinoma of Head and Neck | Head and Neck Neoplasms - blood | Antineoplastic Agents - adverse effects | Cognition Disorders - etiology | Neoplasms, Squamous Cell - drug therapy | Neoplasms, Squamous Cell - radiotherapy | Female | Carcinoma - pathology | Cognition - radiation effects | Affect - drug effects | Pharyngeal Neoplasms - blood | Affect - radiation effects | Carcinoma - radiotherapy | Combined Modality Therapy - adverse effects | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Cisplatin - adverse effects | Aged | Combined Modality Therapy - methods | Temporal Lobe - radiation effects | Care and treatment | Squamous cell carcinoma | Cancer | Index Medicus | BODY FLUIDS | HEAD | NERVOUS SYSTEM | RADIATION DOSES | MEDICINE | THERAPY | CEREBELLUM | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | COMBINED THERAPY | BRAIN | RADIOLOGY | BLOOD | NEOPLASMS | BIOLOGICAL MATERIALS | CENTRAL NERVOUS SYSTEM | STANDARD OF LIVING | CHEMOTHERAPY | NUCLEAR MEDICINE | ORGANS | DISEASES | DOSES | CARCINOMAS | NECK | DOSIMETRY | BODY | MATERIALS
Journal Article
Journal of thoracic oncology, ISSN 1556-0864, 03/2013, Volume 8, Issue 3, pp. 346 - 351
Journal Article
BMC cancer, ISSN 1471-2407, 09/2006, Volume 6, Issue 1, pp. 225 - 225
Background: HER2/neu overexpression is linked to promotion of angiogenesis in breast cancer. We therefore tested the activity of the combination of Trastuzumab... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Cyclophosphamide - administration & dosage | Humans | Middle Aged | Neoplasm Proteins - immunology | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Neoplasm Proteins - antagonists & inhibitors | Cyclophosphamide - adverse effects | Bone Neoplasms - blood supply | Leukopenia - chemically induced | Receptor, ErbB-2 - antagonists & inhibitors | Receptor, ErbB-2 - immunology | Liver Neoplasms - secondary | Combined Modality Therapy | Lung Neoplasms - therapy | Lymphatic Metastasis | Breast Neoplasms - blood supply | Brain Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Remission Induction | Methotrexate - adverse effects | Breast Neoplasms - genetics | Brain Neoplasms - therapy | Immunization, Passive | Methotrexate - administration & dosage | Trastuzumab | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Bone Neoplasms - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Brain Neoplasms - blood supply | Liver Neoplasms - therapy | Ventricular Dysfunction, Left - chemically induced | Breast Neoplasms - therapy | Antibodies, Monoclonal, Humanized | Brain Neoplasms - secondary | Lung Neoplasms - secondary | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Bone Neoplasms - drug therapy | Neutropenia - chemically induced | Lung Neoplasms - blood supply | Drug Administration Schedule | Liver Neoplasms - drug therapy | Treatment Outcome | Gene Amplification | Liver Neoplasms - blood supply | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Genes, erbB-2 | Aged | Index Medicus
Journal Article
Clinical Lung Cancer, ISSN 1525-7304, 2011, Volume 12, Issue 6, pp. 380 - 386
Micro-Abstract We evaluated EGFR and KRAS mutations between 37 paired primary tumors and corresponding metastases in lung adenocarcinoma. A substantial... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | Lung adenocarcinoma | Metastasis | Mutation | Epidermal growth factor receptor | Pleura | Life Sciences & Biomedicine | Oncology | Science & Technology | Adrenal Gland Neoplasms - drug therapy | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Pleural Neoplasms - genetics | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Prognosis | Humans | Middle Aged | Bone Neoplasms - secondary | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Pleural Neoplasms - drug therapy | Brain Neoplasms - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Polymerase Chain Reaction | Aged, 80 and over | Adrenal Gland Neoplasms - secondary | Adult | Female | Adenocarcinoma - genetics | Bone Neoplasms - genetics | Bone Neoplasms - drug therapy | Liver Neoplasms - secondary | Lung Neoplasms - genetics | Pleural Neoplasms - secondary | Liver Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Liver Neoplasms - drug therapy | Brain Neoplasms - genetics | Proto-Oncogene Proteins - genetics | Brain Neoplasms - drug therapy | Mutation - genetics | Adenocarcinoma - drug therapy | Aged | Biomarkers, Tumor - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | DNA, Neoplasm - genetics | Neoplasm Staging | Adrenal Gland Neoplasms - genetics | Index Medicus
Journal Article
Journal Article
Journal of thoracic oncology, ISSN 1556-0864, 07/2011, Volume 6, Issue 7, pp. 1236 - 1241
Journal Article
2007, M.D. Anderson cancer care series, ISBN 0387292020, xii, 364
This book discusses treatment of benign, primary low-grade to high-grade, and metastatic tumors in the brain and spine, as practiced at the University of Texas... 
Brain | Treatment | Spine | Tumors
Book
The lancet oncology, ISSN 1470-2045, 07/2016, Volume 17, Issue 7, pp. 976 - 983
Journal Article